글로벌 요실금 케어 시장 (2023-2030) : 요로 카테터, 소변 주머니

■ 영문 제목 : Continence Care Market Size, Share & Trends Analysis Report By Product (Urinary Catheters, Urinary Bags), By Bag Usage (Sterile Bags, Non-sterile Bags), By Application (Diabetes, BPH), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Research가 발행한 조사보고서이며, 코드는 GRV23NOV082 입니다.■ 상품코드 : GRV23NOV082
■ 조사/발행회사 : Grand View Research
■ 발행일 : 2023년 9월
■ 페이지수 : 121
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (납기:3일)
■ 조사대상 지역 : 세계
■ 산업 분야 : 의료 기기
■ 판매가격 / 옵션 (부가세 10% 별도)
Single User (1인 열람용)USD6,950 ⇒환산￦9,382,500견적의뢰/주문/질문
Multi User (5인 열람용)USD7,950 ⇒환산￦10,732,500견적의뢰/주문/질문
Global/corporate License (기업 열람용)USD9,950 ⇒환산￦13,432,500견적의뢰/구입/질문
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
글로벌 요실금 케어 시장의 성장과 동향
Grand View Research사의 최신 보고서에 따르면, 세계의 요실금 케어 시장 규모는 2023년부터 2030년까지 연평균 5. 5%의 성장률로 2030년까지 34. 9억 달러에 달할 것으로 예측됩니다. 대장암, 방광암, 뇌졸중, 당뇨병 등 다양한 만성 질환의 유병률이 증가했습니다. 기술 발전, 다양한 의료 및 재택 의료 현장에서 무균 제품에 대한 수요 증가, 라이프 스타일 변화, 노인 인구의 증가가 시장 성장의 주요 요인입니다.

고혈압과 당뇨병의 유병률 증가는 요실금(UI)을 유발하는 주요 요인 중 하나이며, 세계적으로 콘틴틴 케어 제품에 대한 수요를 주도하고 있습니다. 예를 들어, 세계보건기구(WHO)가 2023년 발표한 보고서에 따르면, 세계의적으로 약 12. 8억 명이 고혈압을 앓고 있습니다. 이에 따라 관련 질환을 앓고 있는 환자 수가 증가하면서 컨틴즈케어 제품 수요가 급증할 것으로 예상됩니다.

미국 내 컨티넌트 케어 산업에서 사업을 전개하고 있는 기업으로는 Coloplast, Hollister Incorporated, Convatec Group 등이 있습니다. 이들 기업은 다양한 제품과 소모품을 제공하며 제품 품질, 가격, 기술 혁신, 유통망 등의 요인에 따라 경쟁하고 있습니다.

요실금 케어 시장 보고서 주요 내용

- 제품별로는 방광암, 전립선암, 방광 조절 장애와 같은 만성 질환의 유병률 증가로 인해 요도 카테터 분야가 2022년 52. 5%의 시장 점유율을 차지할 것으로 예상됩니다.

- 용도별로는 당뇨병 및 당뇨병 관련 UI의 전 세계 유병률 증가로 인해 당뇨병 분야가 25. 5%의 점유율로 2022년 시장을 장악했습니다.

- 가방 용도별로는 무균 가방 분야가 2022년 64. 9%로 압도적인 시장 점유율을 차지할 것으로 예상되며, 예측 기간 동안에도 견조한 성장세를 보일 것으로 전망됩니다.

- 재택 간호 및 환자 중심 의료 서비스에서 콘티넌스 케어 제품에 대한 수요가 증가함에 따라 2022년 전체 최종 사용자 시장의 43.0%를 차지하는 것은 재택 간호 환경 분야입니다.

- 유럽은 크론병과 궤양성 대장염의 높은 유병률로 인해 2022년 세계 시장에서 48. 5%의 매출 점유율을 차지했으며, Journal of Crohn's and Colitis에 따르면 유럽 전체 인구의 0. 3%가 IBD를 앓고 있다고 전했습니다.
■ 보고서 개요

Chapter 1. 조사 방법 및 범위
Chapter 2. 개요
Chapter 3. 세계의 요실금 케어 시장 변수/동향/범위
Chapter 4. 세계의 요실금 케어 시장 : 제품별 예측 및 동향 분석
Chapter 5. 세계의 요실금 케어 시장 : 용도별 예측 및 동향 분석
Chapter 6. 세계의 요실금 케어 시장 : 가방 용도별 예측 및 동향 분석
Chapter 7. 세계의 요실금 케어 시장 : 최종 용도별 예측 및 동향 분석
Chapter 8. 세계의 요실금 케어 시장 : 지역별 예측 및 동향 분석
Chapter 9. 경쟁 현황

■ 보고서 목차

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. Bag usage
1.1.4. End-user
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. Bag usage outlook
2.2.4. End-user outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Continence Care Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of Urinary Incontinence (UI)
3.2.1.2. Growing geriatric population
3.2.1.3. Rapid technological advancements
3.2.1.4. Rise in demand for minimally invasive procedures
3.2.2. Market restraint analysis
3.2.2.1. Growing concerns regarding Catheter-Associated Urinary Tract Infection (CAUTI)
3.2.3. Market opportunity analysis
3.2.3.1. Presence of online platform
3.2.3.2. Increase in the initiatives to raise incontinence awareness worldwide
3.3. Continence Care Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Covid-19 Impact Analysis
Chapter 4. Continence Care Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Urinary Catheters
4.1.2. Catheter Maintenance/Care
4.1.3. Urinary Bags
4.1.4. Incontinence and Bowel Management
4.2. Product Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Global Surgical Refractor Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
4.5.1. Urinary Catheters
4.5.1.1. Urinary Catheters market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.2. Intermittent Catheters
4.5.1.2.1 Intermittent catheters market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.2.2 Female
4.5.1.2.2.1 Female market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.2.3 Male
4.5.1.2.3.1 Male market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.3. Intermittent Catheter Sets
4.5.1.3.1 Intermittent catheter sets market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.3.2 Female
4.5.1.3.2.1 Female market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.3.3 Male
4.5.1.3.3.1 Male market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.4 Intermittent Catheters Dry
4.5.1.4.1 Intermittent catheters dry market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.5 Indwelling Foley Catheters Silicone
4.5.1.5.1 Indwelling foley catheters silicone market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.5.2 2W
4.5.1.5.2.1 2W market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.5.3 3W
4.5.1.5.3.1 3W market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Catheter Maintenance/Care
4.5.2.1. Catheter Maintenance/Care market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Urinary Bags
4.5.3.1. Urinary Bags market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.2. Pediatric urine bags
4.5.3.2.1 Pediatric urine bags market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.3. Night bags > 1,5L
4.5.3.3.1 Night bags > 1,5L market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.3.2 Sterile
4.5.3.3.2.1 Sterile market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.3.3 Non-Sterile
4.5.3.3.3.1 Non-Sterile market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.4 Bag accessories
4.5.3.4.1 Bag accessories market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.5 Leg urine bags < 1,5L 4.5.3.5.1 Leg urine bags < 1,5L market estimates and forecast 2018 to 2030 (USD Million) 4.5.3.5.2 Sterile 4.5.2.5.2.1 Sterile market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.5.3 Non-Sterile 4.5.3.5.3.1 Non-Sterile market estimates and forecast 2018 to 2030 (USD Million) 4.5.4. Incontinence and Bowel Management 4.5.4.1. Incontinence and Bowel Management market estimates and forecast 2018 to 2030 (USD Million) 4.5.4.2. Male external catheters silicone 4.5.4.2.1 Male external catheters silicone market estimates and forecast 2018 to 2030 (USD Million) 4.5.4.3. Female incontinence device 4.5.4.3.1 Female incontinence device market estimates and forecast 2018 to 2030 (USD Million) 4.5.4.4. Irrigation pump/Transanal irrigation 4.5.4.4.1 Irrigation pump/Transanal irrigation market estimates and forecast 2018 to 2030 (USD Million) Chapter 5. Continence Care Market: Application Estimates & Trend Analysis 5.1. Definitions and Scope 5.1.1. Diabetes 5.1.2. Strokes 5.1.3. Benign Prostatic Hyperplasia (BPH) 5.1.4. Alzheimer 5.1.5. Cerebral Palsy 5.1.6. Parkinson 5.1.7. Prostate Cancer 5.1.8. Spinal Cord Injury 5.1.9. Bladder Cancer 5.1.10. Multiple Sclerosis 5.1.11. Spina Bifida 5.1.12. Others 5.2. Application Market Share, 2018 & 2030 5.3. Segment Dashboard 5.4. Global Continence Care Market by Application Outlook 5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following 5.5.1. Diabetes 5.5.1.1. Diabetes market estimates and forecast 2018 to 2030 (USD Million) 5.5.2. Strokes 5.5.2.1. Strokes market estimates and forecast 2018 to 2030 (USD Million 5.5.3. Benign Prostatic Hyperplasia (BPH) 5.5.3.1. Benign Prostatic Hyperplasia (BPH) market estimates and forecast 2018 to 2030 (USD Million) 5.5.4. Alzheimer 5.5.4.1. Alzheimer market estimates and forecast 2018 to 2030 (USD Million) 5.5.5. Cerebral Palsy) 5.5.5.1. Cerebral palsy market estimates and forecast 2018 to 2030 (USD Million) 5.5.6. Parkinson 5.5.6.1. Parkinson market estimates and forecast 2018 to 2030 (USD Million) 5.5.7. Prostate cancer 5.5.7.1. Prostate cancer market estimates and forecast 2018 to 2030 (USD Million) 5.5.8. Spinal Cord Injury 5.5.8.1. Spinal cord injury market estimates and forecast 2018 to 2030 (USD Million) 5.5.9. Bladder cancer 5.5.9.1. Bladder cancer market estimates and forecast 2018 to 2030 (USD Million) 5.5.10. Multiple sclerosis 5.5.10.1. Multiple sclerosis market estimates and forecast 2018 to 2030 (USD Million) 5.5.11. Spina Bifida 5.5.11.1. Spina Bifida market estimates and forecast 2018 to 2030 (USD Million) 5.5.12. Others 5.5.12.1. Others market estimates and forecast 2018 to 2030 (USD Million) Chapter 6. Continence Care: Bag Usage Estimates & Trend Analysis 6.1. Definitions and Scope 6.1.1. Sterile 6.1.2. Non-Sterile 6.2. Bag Usage Market Share, 2018 & 2030 6.3. Segment Dashboard 6.4. Global Continence Care Market by Bag Usage Outlook 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 6.5.1. Sterile 6.5.1.1. Sterile market estimates and forecast 2018 to 2030 (USD Million) 6.5.2. Non-Sterile 6.5.2.1. Non-sterile market estimates and forecast 2018 to 2030 (USD Million) Chapter 7. Continence Care: End-use Estimates & Trend Analysis 7.1. Definitions and Scope 7.1.1. Home Care Settings 7.1.2. Hospitals 7.1.3. Others 7.2. End-use Market Share, 2018 & 2030 7.3. Segment Dashboard 7.4. Global Continence Care Market by End-use Outlook 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 7.5.1. Home Care Settings 7.5.1.1. Home care settings market estimates and forecast 2018 to 2030 (USD Million) 7.5.2. Hospitals 7.5.2.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million) 7.5.3. Others 7.5.3.1. Others market estimates and forecast 2018 to 2030, (USD Million) Chapter 8. Continence Care Market: Regional Estimates & Trend Analysis 8.1. Regional market share analysis, 2022 & 2030 8.2. Regional Market Dashboard 8.3. Global Regional Market Snapshot 8.4. Regional Market Share and Leading Players, 2022 8.4.1. North America 8.4.2. Europe 8.4.3. Asia Pacific 8.4.4. Latin America 8.4.5. Middle East and Africa 8.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030: 8.6. North America 8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 8.6.2. U.S. 8.6.2.1. Key country dynamics 8.6.2.2. Competitive Scenario 8.6.2.3. Regulatory framework 8.6.2.4. Reimbursement scenario 8.6.2.5. U.S. market estimates and forecasts, 2018 - 2030 8.6.3. Canada 8.6.3.1. Key country dynamics 8.6.3.2. Competitive Scenario 8.6.3.3. Regulatory framework 8.6.3.4. Reimbursement scenario 8.6.3.5. Canada market estimates and forecasts, 2018 - 2030 8.7. Europe 8.7.1. France with DOM-TOM 8.7.1.1. Key country dynamics 8.7.1.2. Competitive Scenario 8.7.1.3. Regulatory framework 8.7.1.4. Reimbursement scenario 8.7.1.5. France with DOM-TOM market estimates and forecasts, 2018 - 2030 8.7.2. UK 8.7.2.1. Key country dynamics 8.7.2.2. Competitive Scenario 8.7.2.3. Regulatory framework 8.7.2.4. Reimbursement scenario 8.7.2.5. UK market estimates and forecasts, 2018 - 2030 8.7.3. Spain 8.7.3.1. Key country dynamics 8.7.3.2. Competitive Scenario 8.7.3.3. Regulatory framework 8.7.3.4. Reimbursement scenario 8.7.3.5. Spain market estimates and forecasts, 2018 - 2030 8.7.4. Italy 8.7.4.1. Key country dynamics 8.7.4.2. Competitive Scenario 8.7.4.3. Regulatory framework 8.7.4.4. Reimbursement scenario 8.7.4.5. Italy market estimates and forecasts, 2018 - 2030 8.7.5. Portugal 8.7.5.1. Key country dynamics 8.7.5.2. Competitive Scenario 8.7.5.3. Regulatory framework 8.7.5.4. Reimbursement scenario 8.7.5.5. Portugal market estimates and forecasts, 2018 - 2030 8.7.6. Netherlands 8.7.6.1. Key country dynamics 8.7.6.2. Competitive Scenario 8.7.6.3. Regulatory framework 8.7.6.4. Reimbursement scenario 8.7.6.5. Netherlands market estimates and forecasts, 2018 - 2030 8.7.7. Ireland 8.7.7.1. Key country dynamics 8.7.7.2. Competitive Scenario 8.7.7.3. Regulatory framework 8.7.7.4. Reimbursement scenario 8.7.7.5. Ireland market estimates and forecasts, 2018 - 2030 8.7.8. Belgium 8.7.8.1. Key country dynamics 8.7.8.2. Competitive Scenario 8.7.8.3. Regulatory framework 8.7.8.4. Reimbursement scenario 8.7.8.5. Belgium market estimates and forecasts, 2018 - 2030 8.7.9. Switzerland 8.7.9.1. Key country dynamics 8.7.9.2. Competitive Scenario 8.7.9.3. Regulatory framework 8.7.9.4. Reimbursement scenario 8.7.9.5. Switzerland market estimates and forecasts, 2018 - 2030 8.7.10. Denmark 8.7.10.1. Key country dynamics 8.7.10.2. Competitive Scenario 8.7.10.3. Regulatory framework 8.7.10.4. Reimbursement scenario 8.7.10.5. Denmark market estimates and forecasts, 2018 - 2030 8.7.11. Sweden 8.7.11.1. Key country dynamics 8.7.11.2. Competitive Scenario 8.7.11.3. Regulatory framework 8.7.11.4. Reimbursement scenario 8.7.11.5. Sweden market estimates and forecasts, 2018 - 2030 8.7.12. Finland 8.7.12.1. Key country dynamics 8.7.12.2. Competitive Scenario 8.7.12.3. Regulatory framework 8.7.12.4. Reimbursement scenario 8.7.12.5. Finland market estimates and forecasts, 2018 - 2030 8.7.13. Norway 8.7.13.1. Key country dynamics 8.7.13.2. Competitive Scenario 8.7.13.3. Regulatory framework 8.7.13.4. Reimbursement scenario 8.7.13.5. Norway market estimates and forecasts, 2018 - 2030 8.7.14. Czech Republic 8.7.14.1. Key country dynamics 8.7.14.2. Competitive Scenario 8.7.14.3. Regulatory framework 8.7.14.4. Reimbursement scenario 8.7.14.5. Czech Republic market estimates and forecasts, 2018 - 2030 8.7.15. Russian Federation 8.7.15.1. Key country dynamics 8.7.15.2. Competitive Scenario 8.7.15.3. Regulatory framework 8.7.15.4. Reimbursement scenario 8.7.15.5. Russian Federation market estimates and forecasts, 2018 - 2030 8.7.16. Poland 8.7.16.1. Key country dynamics 8.7.16.2. Competitive Scenario 8.7.16.3. Regulatory framework 8.7.16.4. Reimbursement scenario 8.7.16.5. Poland market estimates and forecasts, 2018 - 2030 8.7.17. Austria 8.7.17.1. Key country dynamics 8.7.17.2. Competitive Scenario 8.7.17.3. Regulatory framework 8.7.17.4. Reimbursement scenario 8.7.17.5. Austria market estimates and forecasts, 2018 - 2030 8.7.18. Romania 8.7.18.1. Key country dynamics 8.7.18.2. Competitive Scenario 8.7.18.3. Regulatory framework 8.7.18.4. Reimbursement scenario 8.7.18.5. Romania market estimates and forecasts, 2018 - 2030 8.7.19. Slovakia 8.7.19.1. Key country dynamics 8.7.19.2. Competitive Scenario 8.7.19.3. Regulatory framework 8.7.19.4. Reimbursement scenario 8.7.19.5. Slovakia market estimates and forecasts, 2018 - 2030 8.7.20. Slovenia 8.7.20.1. Key country dynamics 8.7.20.2. Competitive Scenario 8.7.20.3. Regulatory framework 8.7.20.4. Reimbursement scenario 8.7.20.5. Slovenia market estimates and forecasts, 2018 - 2030 8.7.21. Serbia 8.7.21.1. Key country dynamics 8.7.21.2. Competitive Scenario 8.7.21.3. Regulatory framework 8.7.21.4. Reimbursement scenario 8.7.21.5. Serbia market estimates and forecasts, 2018 - 2030 8.7.22. Greece 8.7.22.1. Key country dynamics 8.7.22.2. Competitive Scenario 8.7.22.3. Regulatory framework 8.7.22.4. Reimbursement scenario 8.7.22.5. Greece market estimates and forecasts, 2018 - 2030 8.7.23. Turkey 8.7.23.1. Key country dynamics 8.7.23.2. Competitive Scenario 8.7.23.3. Regulatory framework 8.7.23.4. Reimbursement scenario 8.7.23.5. Turkey market estimates and forecasts, 2018 - 2030 8.7.24. Ukraine 8.7.24.1. Key country dynamics 8.7.24.2. Competitive Scenario 8.7.24.3. Regulatory framework 8.7.24.4. Reimbursement scenario 8.7.24.5. Ukraine market estimates and forecasts, 2018 - 2030 8.8. Asia Pacific 8.8.1. Japan 8.8.1.1. Key country dynamics 8.8.1.2. Competitive Scenario 8.8.1.3. Regulatory framework 8.8.1.4. Reimbursement scenario 8.8.1.5. Japan market estimates and forecasts, 2018 - 2030 8.8.2. India 8.8.2.1. Key country dynamics 8.8.2.2. Competitive Scenario 8.8.2.3. Regulatory framework 8.8.2.4. Reimbursement scenario 8.8.2.5. India market estimates and forecasts, 2018 - 2030 8.8.3. China 8.8.3.1. Key country dynamics 8.8.3.2. Competitive Scenario 8.8.3.3. Regulatory framework 8.8.3.4. Reimbursement scenario 8.8.3.5. China market estimates and forecasts, 2018 - 2030 8.8.4. South Korea 8.8.4.1. Key country dynamics 8.8.4.2. Competitive Scenario 8.8.4.3. Regulatory framework 8.8.4.4. Reimbursement scenario 8.8.4.5. South Korea market estimates and forecasts, 2018 - 2030 8.8.5. Australia 8.8.5.1. Key country dynamics 8.8.5.2. Competitive Scenario 8.8.5.3. Regulatory framework 8.8.5.4. Reimbursement scenario 8.8.5.5. Australia market estimates and forecasts, 2018 - 2030 8.8.6. Thailand 8.8.6.1. Key country dynamics 8.8.6.2. Competitive Scenario 8.8.6.3. Regulatory framework 8.8.6.4. Reimbursement scenario 8.8.6.5. Thailand market estimates and forecasts, 2018 - 2030 8.8.7. Malaysia 8.8.7.1. Key country dynamics 8.8.7.2. Competitive Scenario 8.8.7.3. Regulatory framework 8.8.7.4. Reimbursement scenario 8.8.7.5. Thailand market estimates and forecasts, 2018 - 2030 8.9. Latin America 8.9.1. Brazil 8.9.1.1. Key country dynamics 8.9.1.2. Competitive Scenario 8.9.1.3. Regulatory framework 8.9.1.4. Reimbursement scenario 8.9.1.5. Brazil market estimates and forecasts, 2018 - 2030 8.9.2. Chile 8.9.2.1. Key country dynamics 8.9.2.2. Competitive Scenario 8.9.2.3. Regulatory framework 8.9.2.4. Reimbursement scenario 8.9.2.5. Chile market estimates and forecasts, 2018 - 2030 8.9.3. Colombia 8.9.3.1. Key country dynamics 8.9.3.2. Competitive Scenario 8.9.3.3. Regulatory framework 8.9.3.4. Reimbursement scenario 8.9.3.5. Colombia market estimates and forecasts, 2018 - 2030 8.9.4. Argentina 8.9.4.1. Key country dynamics 8.9.4.2. Competitive Scenario 8.9.4.3. Regulatory framework 8.9.4.4. Reimbursement scenario 8.9.4.5. Argentina market estimates and forecasts, 2018 - 2030 8.10. MEA 8.10.1. South Africa 8.10.1.1. Key country dynamics 8.10.1.2. Competitive Scenario 8.10.1.3. Regulatory framework 8.10.1.4. Reimbursement scenario 8.10.1.5. South Africa market estimates and forecasts, 2018 - 2030 8.10.2. Saudi Arabia 8.10.2.1. Key country dynamics 8.10.2.2. Competitive Scenario 8.10.2.3. Regulatory framework 8.10.2.4. Reimbursement scenario 8.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030 8.10.3. UAE 8.10.3.1. Key country dynamics 8.10.3.2. Competitive Scenario 8.10.3.3. Regulatory framework 8.10.3.4. Reimbursement scenario 8.10.3.5. UAE market estimates and forecasts, 2018 - 2030 8.10.4. Kuwait 8.10.4.1. Key country dynamics 8.10.4.2. Competitive Scenario 8.10.4.3. Regulatory framework 8.10.4.4. Reimbursement scenario 8.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030 Chapter 9. Competitive Landscape 9.1. Recent Developments & Impact Analysis, By Key Market Participants 9.2. Company/Competition Categorization 9.2.1. Innovators 9.3. Vendor Landscape 9.3.1. List of key distributors and channel partners 9.3.2. Key customers 9.3.3. Key company market share analysis, 2022 9.3.4. Coloplast Group 9.3.4.1. Company overview 9.3.4.2. Financial performance 9.3.4.3. Product benchmarking 9.3.4.4. Strategic initiatives 9.3.5. Convatec Group PLC 9.3.5.1. Company overview 9.3.5.2. Financial performance 9.3.5.3. Product benchmarking 9.3.5.4. Strategic initiatives 9.3.6. Hollister Incorporated 9.3.6.1. Company overview 9.3.6.2. Financial performance 9.3.6.3. Product benchmarking 9.3.6.4. Strategic initiatives 9.3.7. B. Braun SE 9.3.7.1. Company overview 9.3.7.2. Financial performance 9.3.7.3. Product benchmarking 9.3.7.4. Strategic initiatives 9.3.8. BD 9.3.8.1. Company overview 9.3.8.2. Financial performance 9.3.8.3. Product benchmarking 9.3.8.4. Strategic initiatives 9.3.9. Wellspect HealthCare 9.3.9.1. Company overview 9.3.9.2. Financial performance 9.3.9.3. Product benchmarking 9.3.9.4. Strategic initiatives 9.3.10. Salts Healthcare Ltd. 9.3.10.1. Company overview 9.3.10.2. Financial performance 9.3.10.3. Product benchmarking 9.3.10.4. Strategic initiatives 9.3.11. Welland Medical Ltd. 9.3.11.1. Company overview 9.3.11.2. Financial performance 9.3.11.3. Product benchmarking 9.3.11.4. Strategic initiatives

List of Table

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Examples of comorbidity causing or worsening urinary incontinence in older people:
Table 4 Global continence care market revenue estimates and forecast, by product, 2018 - 2030 (Million)
Table 5 Global continence care market revenue estimates and forecast, by application, 2018 - 2030 (Million)
Table 6 Global continence care market revenue estimates and forecast, by usage, 2018 - 2030 (Million)
Table 7 Global continence care market revenue estimates and forecast, by end-use, 2018 - 2030 (Million)
Table 8 Estimate of the total number of hospitals along with the total number of hospital admissions in the U.S.
※본 조사보고서 [글로벌 요실금 케어 시장 (2023-2030) : 요로 카테터, 소변 주머니] (코드 : GRV23NOV082) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [글로벌 요실금 케어 시장 (2023-2030) : 요로 카테터, 소변 주머니] 에 대해서 E메일 문의는 여기를 클릭하세요.
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

  • 글로벌 펩티드 약물 복합체 시장 (2023-2030) : 루테튬, 멜플루펜, ANG1005, BT1718, CBX-12, 기타 파이프 라인
    GRV23NOV280 / Grand View Research / 2023년 9월 / 글로벌 펩타이드 약물 복합체 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 펩타이드 약물 복합체 시장은 2030년까지 42억 1000만 달러에 달할 것으로 예상되며, 예측 기간 동안 28. 58%의...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변동, 동향, 범위 Chapter 4. 세계의 펩티드 약물 복합체 시장 : 유형별 예측 및 동향 분석 Chapter 5. 세계의 펩티드 약물 복합체 시장 : 제품별 예측 및 동향 분석 Chapter 6. 세계의 펩티드 약물 복합체 시장 : 지역별...
  • 글로벌 카르바페넴 시장 (2023-2030) : 메로펜, 이미페넴, 에르타페넴
    GRV23NOV065 / Grand View Research / 2023년 9월 / 글로벌 카르바페넴 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 카르바페넴 시장 규모는 2030년까지 52. 4억 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 연평균 4. 78%의 성장률을 기록할 것으로...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변수, 동향 및 범위 Chapter 4. 세계의 카르바페넴 시장 : 약품 종류별 예측 및 동향 분석 Chapter 5. 세계의 카르바페넴 시장 : 용도별 예측 및 동향 분석 Chapter 6. 세계의 카르바페넴 시장 : 유통 채널별 예측 및 동향...
  • 세계의 네뷸라이저 시장 (2023~2030) : 제트, 메쉬, 초음파
    GRV23MA046 / Grand View Research / 2023년 1월 / 미국 Grand View Research (그랜드뷰리서치)는 세계의 네뷸라이저 시장 규모가 2023년부터 2030년 사이에 연평균 5.9% 성장하여, 2030년에는 17억 달러에 달할 것으로 전망하고 있습니다. 본 조사 자료는 세계의 네뷸라이저 시장을 조사 및...Nebulizer Market Growth & Trends The global nebulizer market size is expected to reach USD 1.70 billion by 2030, expanding at a CAGR of 5.9%, from 2023 to 2030, according to a new report by Grand View Research Inc., Rising incidence rate of chronic respiratory diseases, increasing demand for home...
  • 글로벌 형광 in situ 하이브리다이제이션 (FISH) 프로브 시장 (2023-2030) : Flow FISH, Q FISH
    GRV23NOV118 / Grand View Research / 2023년 9월 / 글로벌 형광 in situ 하이브리다이제이션 (FISH) 프로브 시장의 성장 및 동향 세계의 형광 in situ 하이브리다이제이션 (FISH) 프로브 시장 규모는 예측 기간 동안 7. 6%의 CAGR을 기록하며 2030년까지 14. 9억...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 세계의 형광 in situ 하이브리다이제이션 (FISH) 프로브 시장 변수/동향/범위 Chapter 4. 세계의 형광 in situ 하이브리다이제이션 (FISH) 프로브 시장 : 기술별 예측 및 동향 분석 Chapter 5. 세계의 형광 in situ 하이브리다이제이션 (FISH) 프로브 시장 : 유형별 예측 및...
  • 글로벌 수술용 붐 시장 (2023-2030) : 기기용 붐, 마취용 붐, 기타 붐
    GRV23NOV246 / Grand View Research / 2023년 9월 / 글로벌 수술용 붐 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 수술용 붐 시장 규모는 2030년까지 6억 1837만 달러에 달할 것으로 예상되며, CAGR은 5. 21%를 기록할 것으로 추정됩니다....Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변동, 동향, 범위 Chapter 4. 세계의 수술용 붐 시장 : 제품 유형별 예측 및 동향 분석 Chapter 5. 세계의 수술용 붐 시장 : 설치별 예측 및 동향 분석 Chapter 6. 세계의 수술용 붐 시장 : 최종 용도별 예측...